Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.46 |
| ▸ | GABRD | O14764 | 2/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.46 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.46 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.46 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.46 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.46 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.46 |
| ▸ | GABRE | P78334 | 2/20 | 0.46 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.46 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.46 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.46 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.46 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.45 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.45 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.45 |
| ▸ | PGR | P06401 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL60920 | 1.00 | GABRP (0.46) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL6061178 | 0.88 | BHMT (0.44) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL2377939 | 0.85 | CACNA2D1 (0.56) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL2763515 | 0.85 | CACNA2D1 (0.56) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL4996654 | 0.85 | GABRP (0.46) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL288273 | 0.85 | CACNA2D1 (0.56) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL8510926 | 0.83 | CACNA2D1 (0.43) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Hydrochloric Acid SCHEMBL10977884 | 0.83 | CACNA2D1 (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Hydrochloric Acid SCHEMBL10977886 | 0.83 | CACNA2D1 (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Acetic Acid SCHEMBL2853697 | 0.81 | CACNA2D1 (0.52) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11688519-B2 | Method and system for monitoring the gut health of an individual | TATA CONSULTANCY SERVICES LIMITED (IN) | 2023-06-27 | — | — | US | claimed |
| US-11452746-B2 | Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases | WAGENINGEN UNIVERSITEIT (NL) | 2022-09-27 | — | — | US | claimed |
| US-11426436-B2 | Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases | WAGENINGEN UNIVERSITEIT (NL) | 2022-08-30 | — | — | US | claimed |
| CN-106119113-B | Organisms for the production of 1, 3-butanediol | 基因组股份公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20240269197-A1 | INSULIN-SENSITIZING AGENT AND BUTYRATE-PRODUCING BACTERIUM | Caelus Lifesciences IP B.V. (NL) | 2024-08-15 | — | — | US | disclosed |
| EP-4346857-A1 | INSULIN-SENSITIZING AGENT AND BUTYRATE-PRODUCING BACTERIUM | Caelus Pharmaceuticals B.V. (NL) | 2024-04-10 | — | — | EP | disclosed |
| EP-4324882-A2 | BINDERS | Knauf Insulation SPRL (BE) | 2024-02-21 | — | — | EP | disclosed |
| EP-3146010-B1 | BINDERS | KNAUF INSULATION INC (US) | 2023-12-13 | — | — | EP | disclosed |
| EP-3865569-B1 | ORGANISMS FOR THE PRODUCTION OF 1,3-BUTANEDIOL | GENOMATICA INC (US) | 2023-10-04 | — | — | EP | disclosed |
| US-20230159979-A1 | TRANSDUCERS, NANOPARTICLE TRANSDUCER DEVICES AND SYSTEMS, AND RELATED METHODS OF USE | UNIVERSITY OF WASHINGTON (US) | 2023-05-25 | — | — | US | disclosed |
| CN-113755462-B | Beta-amino acid dehydrogenase mutant and application thereof | 中国科学院天津工业生物技术研究所 | 2023-04-18 | — | — | CN | disclosed |
| WO-2008073918-A1 | NON-STANDARD AMINO ACID CONJUGATES OF AMPHETAMINE AND PROCESSES FOR MAKING AND USING THE SAME | KEMPHARM, INC. (US) | 2008-06-19 | — | — | WO | disclosed |
| US-20080139653-A1 | Non-standard amino acid conjugates of amphetamine and processes for making and using the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-06-12 | — | — | US | disclosed |
| US-20050118665-A1 | Methods for conducting assays for enzyme activity on protein microarrays | PROTOMETRIX, INC. | 2005-06-02 | — | — | US | disclosed |
| CN-1083460-C | Method for producing crosslinked polyaspartic acid resin | MITSUI CHEMICALS LNC (JP) | 2002-04-24 | — | — | CN | disclosed |
| US-6346569-B1 | DISPERSING FEED POLYSUCCINIMIDE WITH DISPERSANT, REACTING DISPERSED POLYSUCCINIMIDE WITH CROSS-LINKING AGENT | MITSUI CHEMICALS, INC. (JP) | 2002-02-12 | — | — | US | disclosed |
| US-6072024-A | Production process of cross-linked polyaspartic acid resin | MITSUI CHEMICALS, INC. (JP) | 2000-06-06 | — | — | US | disclosed |
| EP-0885970-A1 | METHOD FOR ASSAYING AMMONIA AND COMPOSITION THEREFOR | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1998-12-23 | — | — | EP | disclosed |
| EP-0866084-A2 | Production process of cross-linked polyaspartic acid resin | Mitsui Chemicals, Inc. (JP) | 1998-09-23 | — | — | EP | disclosed |
| EP-0308983-A2 | NMR imaging with Mn(II) coordination compositions | SALUTAR, INC. (US) | 1989-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240269197-A1 | INSULIN-SENSITIZING AGENT AND BUTYRATE-PRODUCING BACTERIUM | CPT1A, GPR119, IRS1 | GABRP 349/4885GABRD 591/4885GABRA1 298/4885 |
| US-20080139653-A1 | Non-standard amino acid conjugates of amphetamine and processes for making and using the same | SLC6A3, AADAT, SLC6A2 | GABRP 433/4885GABRD 582/4885GABRA1 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.